INE474Q01031
INE474Q01031
GLOBAL HEALTH LIMITED
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 352.75B EUR | 352.85B EUR | 258.19B EUR | 318.46B EUR |
Enterprise Value | 353.38B EUR | 352.85B EUR | 268.81B EUR | 318.46B EUR |
Valuation Multiples | ||||
Trailing P/E | 63.48x | 63.44x | 46.4x | 77.21x |
Forward P/E | 39.05x | -- | -- | -- |
Price to Sales | 7.53x | 7.53x | 5.85x | 9.8x |
Price to Book | 8.9x | -- | 6.52x | -- |
EV/Revenue | 7.55x | 7.53x | 6.1x | 9.8x |
EV/EBITDA | 36.5x | 32.7x | 26.41x | 43.2x |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -- | -- | -- | -- |